Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Vorabbekanntmachung Finanzberichte News: 3U HOLDING AG (EQS) +++ 3U HOLDING Aktie +3,49%

3SBIO Aktie

 >3SBIO Aktienkurs 
3.28 EUR    -4.1%    (Tradegate)
Ask: 3.4 EUR / 1465 Stück
Bid: 3.28 EUR / 1527 Stück
Tagesumsatz: 1 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
3SBIO Aktie über LYNX handeln
>3SBIO Performance
1 Woche: -0,6%
1 Monat: -1,7%
3 Monate: +3,7%
6 Monate: +57,9%
1 Jahr: +384,6%
laufendes Jahr: +364,6%
>3SBIO Aktie
Name:  3SBIO INC. DL -,00001
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  KYG8875G1029 / A14T7Q
Symbol/ Ticker:  83B (Frankfurt)
Kürzel:  FRA:83B, ETR:83B, 83B:GR
Index:  -
Webseite:  https://www.3sbio.com/
Profil:  3SBio Inc. is a prominent biotechnology company pr..
>Volltext..
Marktkapitalisierung:  8405.62 Mio. EUR
Unternehmenswert:  8156.96 Mio. EUR
Umsatz:  1074.52 Mio. EUR
EBITDA:  336.78 Mio. EUR
Nettogewinn:  279.03 Mio. EUR
Gewinn je Aktie:  0.12 EUR
Schulden:  224.85 Mio. EUR
Liquide Mittel:  223.27 Mio. EUR
Operativer Cashflow:  414.86 Mio. EUR
Bargeldquote:  1.57
Umsatzwachstum:  -2.76%
Gewinnwachstum:  28.16%
Dividende je Aktie:  0.03 EUR
Dividendenrendite:  0.8%
Dividendenschätzung:  0.79%
Div. Historie:  21.07.25 - 0.02761€
22.07.24 - 0.02761€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  3SBIO, 3 SBIO
Letzte Datenerhebung:  02.12.25
>3SBIO Kennzahlen
Aktien/ Unternehmen:
Aktien: 2392.23 Mio. St.
Frei handelbar: 75.56%
Leerverk. Aktien: -
Rückkaufquote: -0.04%
Mitarbeiter: 5577
Umsatz/Mitarb.: 0.2 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 35.15%
Bewertung:
KGV: 30.18
KGV lG: 7.11
KUV: 8.26
KBV: 4.1
PEG-Ratio: 0.81
EV/EBITDA: 24.22
Rentabilität:
Bruttomarge: 85.37%
Gewinnmarge: 25.97%
Operative Marge: 26.3%
Managementeffizenz:
Gesamtkaprendite: 9.82%
Eigenkaprendite: 15.26%
>3SBIO Peer Group

Es sind 101 Aktien bekannt.
 
02.12.25 - 04:48
China′s 3SBio seeks US$400 million in Hong Kong to boost drug pipeline (SCMP)
 
Chinese drug maker 3SBio plans to raise HK$3.12 billion (US$401 million) by selling a 4.14 per cent stake in the company to fund clinical research in China and the US and expand the global reach of its drug portfolio. The Shenyang-based biopharmaceutical firm has agreed to sell 105.1 million new shares at HK$29.62 each. The placing price represents a 6.5 per cent discount compared with Monday's closing price of HK$31.68, according to its filing with the Hong Kong stock exchange on Tuesday. The......
02.12.25 - 03:00
3SBIO Slumps 5%+ in Early Trading on Plan of 6.5% Discounted Shr Placement (AAStocks)
 
3SBIO (01530.HK) plans a share placement at a 6.5% discount, with net proceeds reaching HKD3.087 billion. This news dented the company's stock price by 3.09% at open today (2nd), bottoming at HKD29.98. It last traded at HKD30.04, down 5.18%, with a trading volume of 4.6345 million shares, amounting to HKD140 million.3SBIO an......
02.12.25 - 02:30
3SBIO Plans 6.5% Discounted Shr Placement to Raise ~$3.09B Net (AAStocks)
 
3SBIO (01530.HK) announced plans to place over 105 million shares, representing approximately 4.14% of the enlarged issued share capital, at a placement price of HKD29.62 per share, which is a 6.5% discount to the previous trading day's closing price of HKD31.68. The net proceeds are expected to reach HKD3.087 billion.Approx......
21.11.25 - 06:42
3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO (SCMP)
 
Mandi, the Alibaba Health-backed consumer healthcare arm being spun off from mainland drug maker 3SBio, filed for an initial public offering in Hong Kong on Friday, betting that its market-leading minoxidil hair-loss products will attract investors. The deal aims to tap into a red-hot Hong Kong market that has seen US$73 billion in equity capital market activity this year, a 232 per cent surge from the same period in 2024, according to data from the London Stock Exchange Group. The company did......
14.11.25 - 11:30
HKD2.3B Southbound Trading Net Inflow to BABA-W (AAStocks)
 
There was HKD2.3 billion, HKD2.2 billion and HKD804.4 million Southbound Trading net inflow to BABA-W (09988.HK), TENCENT (00700.HK) and SMIC (00981.HK).There was HKD174.3 million Southbound Trading net outflow from 3SBIO (01530.HK). For Southbound Trading of Shanghai-Hong Kong Stock Connect, BABA-W (09988.HK) was the most activ......
11.11.25 - 04:30
Research: CMBI Ratings, TPs on CN Pharmas (Table) (AAStocks)
 
Stocks | Investment Ratings | Target Prices 3 3SBIO (01530.HK) | Buy | HKD37.58GUSHENGTANG (02273.HK) | Buy | HKD48.28GIANT BIOGENE (02367.HK) | Buy | HKD58.35WUXI XDC (02268.HK) | Buy | HKD74INNOVENT BIO (01801.HK) | Buy | HKD110.62SINO BIOPHARM (01177.HK) | Buy | HKD9.4~AAStocks Financial NewsWeb Site: www.aastocks.com...
03.11.25 - 11:30
HKD1.4B Southbound Trading Net Outflow from SMIC (AAStocks)
 
There was HKD1 billion, HKD993.1 million and HKD325.5 million Southbound Trading net inflow to XIAOMI-W (01810.HK), CNOOC (00883.HK) and 3SBIO (01530.HK).There was HKD1.4 billion, HKD955.8 million and HKD628 million Southbound Trading net outflow from SMIC (00981.HK), BABA-W (09988.HK) and HUA HONG SEMI (01347.HK).For Southbound......
31.10.25 - 11:30
HKD1.2B Southbound Trading Net Outflow from TENCENT (AAStocks)
 
There was HKD646 million and HKD75.5 million Southbound Trading net inflow to XIAOMI-W (01810.HK) and 3SBIO (01530.HK).There was HKD1.2 billion, HKD711.9 million and HKD473.4 million Southbound Trading net outflow from TENCENT (00700.HK), SMIC (00981.HK) and HUA HONG SEMI (01347.HK).For Southbound Trading of Shanghai-Hong Kong S......
05.09.25 - 12:30
HKD2.1B Southbound Trading Net Inflow to BABA-W (AAStocks)
 
There was HKD2.1 billion, HKD2 billion and HKD1.4 billion Southbound Trading net inflow to BABA-W (09988.HK), MEITUAN-W (03690.HK) and HORIZONROBOT-W (09660.HK).There was HKD576.5 million Southbound Trading net outflow from 3SBIO (01530.HK). For Southbound Trading of Shanghai-Hong Kong Stock Connect, BABA-W (09988.HK) was the mo......
05.09.25 - 10:15
Full-day Takeaway: HSI Up 359 pts; HSTI Up 108 pts; XINYI SOLAR Up over 7%; SINO BIOPHARM, CHOW TAI FOOK, CALB, 3SBIO, KEYMED BIO-B Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 359 pts or 1.4% to 25,417. HSTI rose 108 pts or 1.9% to 5,687. HSCEI gained 120 pts or 1.3% to 9,057. Market turnover reached $299.95 billion.Active Heavyweights:TENCENT (00700.HK) closed at $605.5, up 2.2%MEITUAN (03690.HK) closed at $103, up 1.6%BABA (09988.HK) closed at $131.8, up 1.5%XIAOMI (01810.HK) clos......
05.09.25 - 04:15
Research: CICC Lifts 3SBIO TP to $36.5, Raises NP Forecasts (AAStocks)
 
3SBIO (01530.HK)'s 1H25 revenue fell 0.8% YoY to RMB4.356 billion, while net profit attributable to shareholders increased by 24.6% YoY to RMB1.358 billion, according to CICC's research report. Adjusted net profit grew by 2.1% YoY to RMB1.136 billion, in line with market consensus.Considering the revenue recognition from......
08.08.25 - 03:15
MSCI China Index Constituents Change, Adding LAOPU GOLD/ WUXI XDC/ Others (AAStocks)
 
MSCI announced changes in constituents for the MSCI China Index adding 14 stocks and removing 17 stocks. These changes will take effect after the market closes on 26 August.Newly included Hong Kong-listed stocks include 3 3SBIO (01530.HK), CITIC FAMC (02799.HK), LAOPU GOLD (06181.HK), MEITU (01357.HK), NETEASE MUSIC (09899.HK), ......
28.07.25 - 06:15
Research: HSBC Research Lists H-Shrs Most Favored by Domestic Active Mutual Funds/ Southbound Capital in 2Q (Table) (AAStocks)
 
HSBC Global Research released a report listing the H-shares most favored by domestic active mutual funds in 2Q25 as follows:Stock|Industry|Net Buy (RMB)INNOVENT BIO (01801.HK)|Healthcare|5 billion3 3SBIO (01530.HK)|Healthcare|4.9 billionJD HEALTH (06618.HK)|Healthcare|2.9 billionCSPC PHARMA (01093.HK)|Healthcare|1.9 billionHKEX ......
25.07.25 - 11:12
Pfizer, Chinese biotech firm 3SBio complete licensing deal for cancer drug (SCMP)
 
Pfizer and 3SBio have completed a licensing agreement that grants the US pharmaceutical giant worldwide rights to sell the Hong Kong-listed firm's cancer drug, marking the largest deal ever for a single drug in China's biotech industry. First announced in May, the deal will see 3SBio – based in Shenyang, capital of northeastern Liaoning province – receive a US$1.25 billion upfront payment from Pfizer for the exclusive right to sell its cancer drug, SSGJ-707, outside China. Under the terms of......
24.07.25 - 14:01
Pfizer Completes Licensing Agreement With 3SBio For Cancer Drug (AFX)
 
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) Thursday said it has completed the licensing agreement with 3SBio, Inc. for exclusive rights to develop and sell 3SBio's SSGJ-707.As per the deal, 3SBio......
24.07.25 - 06:15
Research: CICC Lists HK Stocks w/ Largest QoQ Gains in Holdings by CN Actively Managed Equity Funds (Table) (AAStocks)
 
Stock│Mkt value of holdings in 2Q25 (RMB)│ Change in mkt value of holdings from 1Q to 2Q (RMB)INNOVENT BIO (01801.HK)│15.531 billion │+10.518 billion 3 3SBIO (01530.HK)│8.52 billion │+7.189 billion POP MART (09992.HK)│15.742 billion │+6.962 billion CSPC PHARMA (01093.HK)│3.89......
23.07.25 - 06:30
Research: UBS Lists HK-listed Stocks w/ Highest UBS Earnings Upside Above Consensus Estimate (Table) (AAStocks)
 
UBS report listed the Buy-rated HK-listed stocks with highest UBS earnings upside above consensus estimate:Shares│UBS vs consensus' comprehensive profit forecast differences for companies in 2025 and 2026CANSINOBIO (06185.HK)│97%CSPC PHARMA (01093.HK)│60%3SBIO (01530.HK)│42%CARSGEN-B (02171.HK)│......
21.07.25 - 08:01
XFRA: 83B: HEUTE EX-KAPITALMASSNAHME / EX CAPITAL ADJUSTMENT TODAY (XETRA)
 
Folgendes Instrument wird heute EX-Kapitalmassnahme gehandelt. Aus technischen Gruenden wird der EX-Indikator heute nicht angezeigt. The following instrument is traded ex capital adjustment today. Due to technical reasons the EX-indicator will not be displayed today. ISIN Short Code Name KYG8875G1029 83B 3SBio Inc....
17.07.25 - 23:42
XFRA: DIVIDEND/INTEREST INFORMATION - 21.07.2025 - EQUBF_01 (XETRA)
 
Das Instrument 83B KYG8875G1029 3SBIO INC. DL -,00001 EQUITY wird cum Dividende/Zinsen gehandelt am 18.07.2025 und ex Dividende/Zinsen am 21.07.2025 The instrument 83B KYG8875G1029 3SBIO INC. DL -,00001 EQUITY has its pre-dividend/interest day on 18.07.2025 and its ex-dividend/interest day on 21.07.2025...
14.07.25 - 10:15
Full-day Takeaway: HSI Closes at 24,203, Up 63 pts; HSTI Closes at 5,283, Up 35 pts; CHINA SHENHUA Up over 5%; SINO BIOPHARM, WH GROUP, SIHUAN PHARM, 3SBIO, CH ENERGY ENG Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 63 pts or 0.3% to 24,203. HSTI rose 35 pts or 0.7% to 5,283. HSCEI gained 45 pts or 0.5% to 8,732. Market turnover reached $210.36 billion.Active Heavyweights:BABA (09988.HK) closed at $106.1, up 1%MEITUAN (03690.HK) closed at $120.9, up 0.8%CCB (00939.HK) closed at $8.41, up 0.7%TENCENT (00700.HK) closed at $......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Blitz trifft den, der rennt. - Sprichwort Ungarn
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!